Literature DB >> 1316932

An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7).

W Held1, A N Shakhov, G Waanders, L Scarpellino, R Luethy, J P Kraehenbuhl, H R MacDonald, H Acha-Orbea.   

Abstract

The classical minor lymphocyte stimulating (Mls) antigens, which induce a strong primary T cell response in vitro, are closely linked to endogenous copies of mouse mammary tumor viruses (MMTV). Expression of Mls genes leads to clonal deletion of T cell subsets expressing specific T cell receptor (TCR) V beta chains. We describe the isolation and characterization of a new exogenous (infectious) MMTV with biological properties similar to the Mls antigen Mls-1a. In vivo administration of either Mls-1a-expressing B cells or the infectious MMTV (SW) led to an increase of T cells expressing V beta 6 followed by their deletion. Surprisingly, different kinetics of deletion were observed with the exogenous virus depending upon the route of infection. Infection through the mucosa led to a slow deletion of V beta 6+ T cells, whereas deletion was rapid after subcutaneous infection. Sequence analysis of the open reading frames in the 3' long terminal repeat of both this exogenous MMTV (SW) and of Mtv-7 (which is closely linked to Mls-1a) revealed striking similarities, particularly in the COOH terminus, which has been implicated in TCR V beta recognition. The identification of an infectious MMTV with the properties of a strong Mls antigen provides a new, powerful tool to study immunity and tolerance in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316932      PMCID: PMC2119252          DOI: 10.1084/jem.175.6.1623

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  66 in total

1.  Genetic control of endogenous murine mammary tumour viruses reinvestigated.

Authors:  P Bentvelzen; J Brinkhof; J J Haaijman
Journal:  Eur J Cancer       Date:  1978-10       Impact factor: 9.162

2.  A maternally inherited superantigen encoded by a mammary tumour virus.

Authors:  P Marrack; E Kushnir; J Kappler
Journal:  Nature       Date:  1991-02-07       Impact factor: 49.962

3.  Programmed cell death and extrathymic reduction of Vbeta8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B.

Authors:  Y Kawabe; A Ochi
Journal:  Nature       Date:  1991-01-17       Impact factor: 49.962

4.  Studies of genetic transmission of mammary tumour virus by C3Hf mice.

Authors:  R van Nie; A A Verstraeten
Journal:  Int J Cancer       Date:  1975-12-15       Impact factor: 7.396

5.  A third T-cell receptor beta-chain variable region gene encodes reactivity to Mls-1a gene products.

Authors:  M P Happ; D L Woodland; E Palmer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

6.  Effect of chemical carcinogen treatment on the immunogenicity of mouse mammary tumors arising from hyperplastic alveolar nodule outgrowth lines.

Authors:  B Ruppert; W Wei; D Medina; G H Heppner
Journal:  J Natl Cancer Inst       Date:  1978-10       Impact factor: 13.506

7.  A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus.

Authors:  Y Choi; J W Kappler; P Marrack
Journal:  Nature       Date:  1991-03-21       Impact factor: 49.962

Review 8.  Mls--a retrovirus exploits the immune system.

Authors:  H Acha-Orbea; E Palmer
Journal:  Immunol Today       Date:  1991-10

9.  Relative V beta transcript levels in thymus and peripheral lymphoid tissues from various mouse strains. Inverse correlation of I-E and Mls expression with relative abundance of several V beta transcripts in peripheral lymphoid tissues.

Authors:  C Y Okada; I L Weissman
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

10.  Acquired Mls-1a-like clonal deletion in Mls-1b mice.

Authors:  M Papiernik; C Pontoux; S Gisselbrecht
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

View more
  39 in total

1.  Complete Nucleotide Sequence of Mouse Mammary Tumor Virus from JYG Chinese Wild Mice: Absence of Bacterial Insertion Sequences in the Cloned Viral gag Gene.

Authors: 
Journal:  Breast Cancer       Date:  1994-12-30       Impact factor: 4.239

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

3.  Retrovirus-induced target cell activation in the early phases of infection: the mouse mammary tumor virus model.

Authors:  C Ardavin; F Luthi; M Andersson; L Scarpellino; P Martin; H Diggelmann; H Acha-Orbea
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  A highly sensitive in vitro infection assay to explore early stages of mouse mammary tumor virus infection.

Authors:  S Vacheron; T Renno; H Acha-Orbea
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  New superantigen specificity created by two amino acid replacements.

Authors:  O A Rosenwasser; S Fairchild; K Tomonari
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

6.  Shared promoter elements between a viral superantigen and the major histocompatibility complex class II-associated invariant chain.

Authors:  J Arroyo; E Winchester; B S McLellan; B T Huber
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

Review 7.  Superantigens related to B cell hyperplasia.

Authors:  N M Ponzio; V K Tsiagbe; G J Thorbecke
Journal:  Springer Semin Immunopathol       Date:  1996

8.  Passive immunization with neutralizing antibodies interrupts the mouse mammary tumor virus life cycle.

Authors:  M Mpandi; L A Otten; C Lavanchy; H Acha-Orbea; D Finke
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  Mouse mammary tumor virus-induced tumorigenesis in sag transgenic mice: a laboratory model of natural selection.

Authors:  T V Golovkina; J A Prescott; S R Ross
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  Systemic antibodies can inhibit mouse mammary tumor virus-driven superantigen response in mucosa-associated lymphoid tissues.

Authors:  D Velin; G Fotopoulos; J P Kraehenbuhl; H Acha-Orbea
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.